High mobility group AT-hook 1 mRNA (HMGA1 mRNA)

High mobility group AT-hook 1 (HMGA1) mRNA is the transcript encoding the HMGA1 protein, a non-histone architectural transcription factor that plays a critical role in chromatin remodeling and gene expression regulation (NIH, 2026). The HMGA1 protein binds to AT-rich regions in the minor groove of DNA, facilitating the assembly of enhanceosomes and promoting an open chromatin state conducive to transcription (Wikipedia, 2024). While highly expressed during embryonic development, HMGA1 levels are typically low in adult tissues but become significantly upregulated in nearly all aggressive cancers, where it drives proliferation, metastasis, and chemoresistance (Oncotarget, 2015). Consequently, HMGA1 mRNA has emerged as a therapeutic target for RNA-based interventions, including small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs), aimed at silencing its expression to inhibit tumor progression (PubMed, 2022). Beyond oncology, HMGA1 mRNA stability is vital for metabolic health; its downregulation or degradation—often mediated by pseudogenes or specific microRNAs—is linked to reduced insulin receptor expression and the development of type 2 diabetes (NIH, 2022). Therapeutic challenges include ensuring tumor-specific delivery to avoid disrupting HMGA1's essential roles in normal stem cell maintenance and metabolic homeostasis (MDPI, 2021).

Other names

HMGIY mRNAHMG-I(Y) mRNAHMGA1 transcriptHigh mobility group protein A1 mRNA

RNA interference (RNAi) or antisense-mediated degradation of HMGA1 mRNA, leading to reduced translation of the HMGA1 protein and subsequent inhibition of oncogenic transcriptional programs.